Brief: Moberg Pharma Q4 EBITDA Loss Narrows To SEK 7.8 Mln
Feb 11 (Reuters) - Moberg Pharma AB (publ) MBPH.ST :
* Q4 NET REVENUE SEK 1.0 MILLION (0)
* Q4 EBITDA SEK -7.8 MILLION (-8.0)
Source text: ID:nWkr4hrVGd
Further company coverage: MBPH.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Moberg Pharma AB (publ)
See all newsSweden's Moberg Pharma Q2 loss narrows as revenue rises
Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
Brief: Moberg Pharma Names Vaidrius Navikas Chief Medical Officer
Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains